top of page
Benjamin Zhang
Admin
More actions
Profile
Join date: Sep 1, 2025
Posts (17)
Oct 20, 2025 ∙ 2 min
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today rang the Opening Bell at Nasdaq MarketSite in New York to celebrate its public listing on the Nasdaq Global Market.
20
0
Oct 9, 2025 ∙ 2 min
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that its business partner, EG Biomed US Inc. (“EG BioMed”) one of the Company’s licensing partners for pancreatic and breast cancer detection has been accredited by the College of American Pathologists’ (CAP) Laboratory Accreditation Program for its CLIA-certified laboratory in Bothell, Washington.
8
0
Oct 1, 2025 ∙ 5 min
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced its unaudited financial results for the six months ended June 30, 2025.
52
0
bottom of page